Back To Schedule
Thursday, July 1 • 2:00pm - 3:00pm
#439 SL: Preparing Medical Information for Emergency Use Authorization (EUA) to a Full Launch During the COVID-19 Pandemic

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Component Type: Forum
Level: Basic
CE: ACPE 1.00 Knowledge UAN: 0286-0000-21-661-L04-P; CME 1.00; IACET 1.00; RN 1.00

Supporting Emergency Use Authorization (EUA) during the unprecedented times of a global pandemic is challenging. A panel discussion about Emergency Use Authorization (EUA) will bring together key leaders in Medical Information across the pharmaceutical industry. The industry leaders will share the hurdle of regulatory requirements in each country and overcoming of these challenges in preparation for EUA in amidst of a global pandemic. Panelist will share key learnings from a successful global MI product launch during the COVID-19 pandemic including scientific response document planning, collaboration with internal partners, communicating key metrics and insights with internal stakeholders, scaling-up internal resources and training, and supporting global MI operations. Sharing key learnings from their EUA experiences will help to inform our industry with how to adapt key strategic planning initiatives for Medical Information to meet the challenges of EUA.

Learning Objectives

Discuss the differences between medical support for Emergency Use Authorization (EUA) and traditional product approval; Describe best practices for Medical Information (MI) strategic planning for EUA including MI standard response documents, FAQs, internal trainings, and MI contact center operations. • Describe key learnings for MI during pre-EUA, after EUA approval, and the transition to approval


Truc Dinh, PharmD


Laura Miesle, PharmD

Barbara Maria Bonetti, PharmD

avatar for Truc Dinh

Truc Dinh

Senior Manager, Global Medical Information, Gilead Sciences, Inc.
Truc Dinh is a Senior Manager in Global Medical Information at Gilead Sciences where she is responsible for managing global medical information content for the COVID-19 and Liver Diseases therapeutic areas. She received a Bachelors of Art degree in Public Health and Public Policy... Read More →
avatar for Barbara Bonetti

Barbara Bonetti

Director, Medical Customer Interface, Pfizer Inc, United States
Barbara Bonetti, PharmD, is the Medical Customer Interface Director within Pfizer Medical Information and currently leads the team that oversees the Pfizer Medical Information contact center operations for U.S. and Canada. She has over 20 years of experience working in various Medical... Read More →

Laura Miesle

Consultant, Global Medical Information - COVID-19 and Biomedicines, Eli Lilly and Company, United States

Thursday July 1, 2021 2:00pm - 3:00pm EDT
TBD Virtual Event Horsham, PA 19044
  04: MedAffairs-SciComm, Forum |   02: ClinTrials -ClinOps, Forum |   09: Regulatory, Forum